GENESCO INC
For the period ended Jan 31, 2026. Filed Mar 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Mar 25, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statements Nos. 333-08463, 333-104908, 333-40249, 333-128201, 333-160339, 333-180463, 333-218670, 333-248715, 333-274394, 333-282063 and 333-290298 on Form S-8 of our reports dated March 25, 2026 relating to the financial statements of Genesco Inc. and the effectiveness of Genesco Inc.'s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Genesco Inc. for the year ended January 31, 2026.
/s/ Deloitte & Touche LLP
Nashville, Tennessee
March 25, 2026
Consent of Indepe ndent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration statement (Form S-8 No. 333-08463) of Genesco Inc.,
(2) Registration statement (Form S-8 No. 333-104908) of Genesco Inc.,
(3) Registration statement (Form S-8 No. 333-40249) of Genesco Inc.,
(4) Registration statement (Form S-8 No. 333-128201) of Genesco Inc.,
(5) Registration statement (Form S-8 No. 333-160339) of Genesco Inc.,
(6) Registration statement (Form S-8 No. 333-180463) of Genesco Inc.,
(7) Registration statement (Form S-8 No. 333-218670) of Genesco Inc.,
(8) Registration statement (Form S-8 No. 333-248715) of Genesco Inc.,
(9) Registration statement (Form S-8 No. 333-274394) of Genesco Inc.,
(10) Registration statement (Form S-8 No. 333-282063) of Genesco Inc., and
(11) Registration statement (Form S-8 No. 333-290298) of Genesco Inc.
of our report dated March 26, 2025, with respect to the consolidated financial statements of Genesco Inc. and Subsidiaries included in this Annual Report (Form 10-K) of Genesco Inc. for the year ended January 31, 2026, and the financial statement schedule of Genesco Inc. and Subsidiaries included herein.
/s/ Ernst & Young LLP
Nashville, Tennessee
March 25, 2026
SIGNAT URES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| GENESCO INC. | ||
| By: | /s/Mimi Eckel Vaughn | |
|---|---|---|
| Mimi Eckel Vaughn | ||
| Board Chair, President, Chief Executive Officer and | ||
| Interim Chief Financial Officer | ||
Date: March 25, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the 4th day of February, 2026.
| /s/Mimi Eckel Vaughn | Board Chair, President, Chief Executive Officer and |
|---|---|
| Mimi Eckel Vaughn | Interim Chief Financial Officer |
| (Principal Executive Officer & Principal Financial Officer) | |
| /s/Cassandra E. Harris | Principal Accounting Officer |
| Cassandra E. Harris | |
| Directors: | |
| Joanna Barsh* | Angel R. Martinez * |
| Matthew Bilunas* | Mary Meixelsperger* |
| Carolyn Bojanowski * | Gregory A. Sandfort* |
| John F. Lambros.* | Mimi E. Vaughn* |
| Thurgood Marshall, Jr.* | |
| *By | /s/Scott E. Becker |
|---|---|
| Scott E. Becker | |
| Attorney-In-Fact |
Genesco Inc.
and Subsidiaries
Financial Statement Schedule
January 31, 2026
Schedule 2
Valuation and Qualifying Accounts
Year Ended January 31, 2026
| (In thousands) | BeginningBalance | Chargedto Profitand Loss | Reductions | EndingBalance |
|---|---|---|---|---|
| Allowances deducted from assets in the balance sheet: | ||||
| Accounts Receivable Allowances | $2,522 | $67 | $(212) | $2,377 |
| Markdown Allowance (1) | $7,678 | $1,500 | $(1,428) | $7,750 |
Year Ended February 1, 2025
| (In thousands) | BeginningBalance | Chargedto Profitand Loss | Reductions | EndingBalance |
|---|---|---|---|---|
| Allowances deducted from assets in the balance sheet: | ||||
| Accounts Receivable Allowances | $4,266 | $124 | $(1,868) | $2,522 |
| Markdown Allowance (1) | $6,229 | $2,945 | $(1,496) | $7,678 |
Year Ended February 3, 2024
| (In thousands) | BeginningBalance | Chargedto Profitand Loss | Reductions | EndingBalance |
|---|---|---|---|---|
| Allowances deducted from assets in the balance sheet: | ||||
| Accounts Receivable Allowances | $3,710 | $662 | $(106) | $4,266 |
| Markdown Allowance (1) | $6,018 | $3,818 | $(3,607) | $6,229 |
(1)
Reflects adjustment of merchandise inventories to realizable value. Charged to Profit and Loss column represents increases to the allowance and the Reductions column represents decreases to the allowance based on quarterly assessments of the allowance.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.